Hepatitis B Program definition

Hepatitis B Program means the identification, development, manufacture and/or use of any Hepatitis B Products in Accordance with the Development Plan.
Sample 1Sample 2Sample 3

Examples of Hepatitis B Program in a sentence

  • A Perinatal Hepatitis B Program Enhanced Surveillance project found that longer intervals after the final vaccine dose before PVST is performed resulted in fewer infant anti-HBs results indicating immunity (at least 10 milli-International Units per milliliter or greater) to hepatitis B.

  • Perinatal Hepatitis B Initiative Collaboration (e.g., chart review data collection)In December 2010, a meeting between three HIV Perinatal Collaborative members and the Perinatal Hepatitis B Coordinator for LA County convened to discuss the successes, challenges, and lessons learned from the well established Perinatal Hepatitis B Program.

  • Namely, the Asian American Hepatitis B Program , a NYC City Council funded coalition dedicated to reducing the burden of hepatitis B infection in the Asian American community through increased awareness, outreach, education, screening, vaccination and follow-up care.

  • Communicable Disease ServicesWhy This Work MattersA Fresh Start for a Premature Baby by Marta Fisher Collaboration between CDS, local healthcare providers, and hospitals is critical to the success of the Perinatal Hepatitis B Program.

  • LSSO London had overall capital resources available of US$151.2m at this date.In the 2020/21 financial year the Club established The London P&I Insurance Company (Europe) Limited (“LSSO Europe”), a wholly owned subsidiary incorporated and registered in Cyprus.

  • The Institute Directors shall be in charge of maintaining the proper functioning and growth of their respective Institute, and developing a plan of action that covers their term in office.

  • The outcome of this meeting was to set up a follow-up meeting with additional Perinatal Collaborative members and Perinatal Hepatitis B Program staff to explore the possibility of adding HIV testing questions to the perinatal Hepatitis B chart audits.

  • Initiate a Pennsylvania Department of Health (DOH) “Perinatal Hepatitis B Case and Contact Report for DOH,” Perinatal Hepatitis B Program, by completing all fields as the information becomes available.

  • AK Party’s performance in power has become an eye-opener for the Europeans, and the new perception about Western stra- tegic needs has solved the seemingly insoluble tension between the U.S. and the EU regarding Turkey.

  • Local health departments must actively target underserved communities.Perinatal Hepatitis B ProgramThe goal of the Perinatal Hepatitis B Program is to reduce transmission of Hepatitis B virus to infants.

Related to Hepatitis B Program

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Cell means a single encased electrochemical unit containing one positive and one negative electrode which exhibits a voltage differential across its two terminals.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • HIV/AIDS means human immunodeficiency virus/acquired immune deficiency syndrome;

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • HIV means human immunodeficiency virus.

  • Tobacco product manufacturer means an entity that after the date of enactment of this act directly (and not exclusively through any affiliate) meets 1 or more of the following:

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.